Eli D. Ehrenpreis MD, is a nationally recognized academic gastroenterologist and clinical pharmacologist. He currently serves as Research Director for the Internal Medicine Residency Program at Advocate Lutheran General Hospital in Park Ridge, Illinois, and is the founder and CEO of E2Bio Consultants. Dr. Ehrenpreis completed fellowships in gastroenterology and clinical pharmacology at Northwestern University. He has held academic positions at the Cleveland Clinic, Rush, and the University of Chicago, where he served as Director of the Gastroenterology Fellowship. Dr. Ehrenpreis has authored over 180 peer-reviewed articles, 20 book chapters, and six books. He has receivedseveral NIH grants, discovered and developed new treatments for Crohn’s disease, mesenteric panniculitis, and radiation proctopathy, and serves on multiple journal editorial boards.